Massimo Zucchetti

7.0k total citations · 1 hit paper
170 papers, 4.8k citations indexed

About

Massimo Zucchetti is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Massimo Zucchetti has authored 170 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 72 papers in Oncology and 26 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Massimo Zucchetti's work include Cancer therapeutics and mechanisms (34 papers), Cancer Treatment and Pharmacology (31 papers) and Lung Cancer Research Studies (16 papers). Massimo Zucchetti is often cited by papers focused on Cancer therapeutics and mechanisms (34 papers), Cancer Treatment and Pharmacology (31 papers) and Lung Cancer Research Studies (16 papers). Massimo Zucchetti collaborates with scholars based in Italy, Switzerland and Germany. Massimo Zucchetti's co-authors include Maurizio D’Incalci, Roberta Frapolli, Cristiana Sessa, Lavinia Morosi, Tina Colombo, M.G. Donelli, Raffaella Giavazzi, Cristina Sottani, Enrico Davoli and Carla Minoia and has published in prestigious journals such as Journal of Clinical Oncology, Blood and ACS Nano.

In The Last Decade

Massimo Zucchetti

170 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High-dose vitamin C enhances cancer immunotherapy

2020 199 citations Tommaso Ceruti, Maurizio D’Incalci et al. profile →

Peers

Countries citing papers authored by Massimo Zucchetti

Since Specialization

Citations

This map shows the geographic impact of Massimo Zucchetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Zucchetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Zucchetti more than expected).

Fields of papers citing papers by Massimo Zucchetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Zucchetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Zucchetti. The network helps show where Massimo Zucchetti may publish in the future.

Co-authorship network of co-authors of Massimo Zucchetti

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Zucchetti. A scholar is included among the top collaborators of Massimo Zucchetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Zucchetti. Massimo Zucchetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Validated LC-MS/MS Assay for the Quantitative Determination of Fenretinide in Plasma and Tumor and Its Application in a Pharmacokinetic Study in Mice of a Novel Oral Nanoformulation of Fenretinide 2024 ·Pharmaceutics ·Cristina Matteo, Isabella Orienti, Adriana Eramo, Ann Zeuner, (unknown), Alice Passoni, Renzo Bagnati, (unknown), Ezia Bello, Massimo Zucchetti, Roberta Frapolli	2
2	Two Different Responsive Organosilica Nanocarriers to Combine Chemo- and Immunotherapy against Cancer 2024 ·ACS Omega ·María Sancho‐Albero, (unknown), (unknown), Cristina Matteo, Chiara Grasselli, Massimo Zucchetti, Roberta Frapolli, Claudia Nastasi, Luisa De Cola	1
3	Enhancing Pt(IV) Complexes' Anticancer Activity upon Encapsulation in Stimuli‐Responsive Nanocages 2023 ·Advanced Healthcare Materials ·María Sancho‐Albero, Giorgio Facchetti, Nicolò Panini, (unknown), Ezia Bello, Isabella Rimoldi, Massimo Zucchetti, Roberta Frapolli, Luisa De Cola	13
4	Development and Validation of a HPLC–MS/MS Method to Measure Nifuroxazide and Its Application in Healthy and Glioblastoma-Bearing Mice 2022 ·Pharmaceutics ·Tommaso Ceruti, Quintino Giorgio D’Alessandris, Roberta Frapolli, Jay Gopalakrishnan, Mariachiara Buccarelli, (unknown), Liverana Lauretti, Lucia Ricci‐Vitiani, Roberto Pallini, Massimo Zucchetti	2
5	Pharmacological and clinical monitoring in children with acute lymphoblastic leukemia treated with a biogeneric PEG‐l‐asparaginase product 2022 ·Pediatric Blood & Cancer ·Cristina Matteo, Antonella Colombini, Laura Rachele Bettini, Luca Porcu, (unknown), Tommaso Ceruti, Daniela Silvestri, (unknown), (unknown), (unknown), Claudia Nastasi, Massimo Zucchetti, Carmelo Rizzari	4
6	Population Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia: Treatment Phase Dependency and Predictivity in Case of Missing Data 2021 ·European Journal of Drug Metabolism and Pharmacokinetics ·(unknown), Gudrun Würthwein, Claudia Lanvers‐Kaminsky, (unknown), Joachim Gerß, Anja Möricke, Martin Zimmermann, Jan Starý, Petr Smíšek, Martin Schrappe, Carmelo Rizzari, Massimo Zucchetti, Georg Hempel, Sebastian G. Wicha, Joachim Boos	9
7	PEGylated recombinant human hyaluronidase (PEGPH20) pre-treatment improves intra-tumour distribution and efficacy of paclitaxel in preclinical models 2021 ·Journal of Experimental & Clinical Cancer Research ·Lavinia Morosi, (unknown), Paolo Ubezio, Ilaria Fuso Nerini, Lucia Minoli, Luca Porcu, Nicolò Panini, (unknown), Barbara Blouw, David W. Kang, Enrico Davoli, Massimo Zucchetti, Maurizio D’Incalci, Roberta Frapolli	47
8	Venetoclax penetrates in cerebrospinal fluid of an acute myeloid leukemia patient with leptomeningeal involvement 2021 ·Cancer Chemotherapy and Pharmacology ·(unknown), Cristina Matteo, Salvatore Leotta, (unknown), (unknown), (unknown), Nunziatina Laura Parrinello, (unknown), (unknown), Massimo Zucchetti, Giuseppe Milone, Francesco Di Raimondo	10
9	Quantitative measurement of pioglitazone in neoplastic and normal tissues by AP-MALDI mass spectrometry imaging 2021 ·Talanta ·Lavinia Morosi, Cristina Matteo, (unknown), Tommaso Ceruti, Ilaria Fuso Nerini, Ezia Bello, Roberta Frapolli, Maurizio D’Incalci, Massimo Zucchetti, Enrico Davoli	12
10	Pharmacokinetics, safety, and activity of trabectedin as first‐line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma Group 2020 ·Cancer ·Federica Grosso, Lorenzo D’Ambrosio, Massimo Zucchetti, Toni Ibrahim, Stefano Tamberi, Cristina Matteo, Eliana Rulli, Danila Comandini, Emanuela Palmerini, Giacomo Giulio Baldi, Andrea DeCensi, M. Bergaglio, (unknown), Emanuela Marchesi, Giacomo Siri, Maurizio D’Incalci, Giovanni Grignani	20
11	Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study 2019 ·Journal of Gynecologic Oncology ·Marco Petrillo, Massimo Zucchetti, Stefano Cianci, Lavinia Morosi, Carlo Ronsini, Andrea Colombo, Maurizio D’Incalci, Giovanni Scambia, Anna Fagotti	24
12	Readily prepared biodegradable nanoparticles to formulate poorly water soluble drugs improving their pharmacological properties: The example of trabectedin 2018 ·Journal of Controlled Release ·Umberto Capasso Palmiero, Lavinia Morosi, Ezia Bello, (unknown), Roberta Frapolli, Cristina Matteo, (unknown), Massimo Zucchetti, Lucia Minoli, Marcella De Maglie, (unknown), Massimo Morbidelli, Maurizio D’Incalci, Davide Moscatelli	11
13	Self‐Assembling PCL‐Based Nanoparticles as PTX Solubility Enhancer Excipients 2018 ·Macromolecular Bioscience ·Umberto Capasso Palmiero, Lavinia Morosi, Monica Lupi, (unknown), Roberta Frapolli, Massimo Zucchetti, Paolo Ubezio, Massimo Morbidelli, Maurizio D’Incalci, Ezia Bello, Davide Moscatelli	9
14	A Nanostructured Matrices Assessment to Study Drug Distribution in Solid Tumor Tissues by Mass Spectrometry Imaging 2017 ·Nanomaterials ·Silvia Giordano, V. Pifferi, Lavinia Morosi, (unknown), L. Falciola, G. Cappelletti, Sonja Visentin, Simonetta Andrea Licandro, Roberta Frapolli, Massimo Zucchetti, Roberta Pastorelli, Laura Brunelli, Maurizio D’Incalci, Enrico Davoli	17
15	High Penetration of Paclitaxel in Abdominal Wall of Rabbits after Hyperthermic Intraperitoneal Administration of Nab-Paclitaxel Compared to Standard Paclitaxel Formulation 2017 ·Pharmaceutical Research ·Federico Coccolini, Fabio Acocella, Lavinia Morosi, Stefano Brizzola, (unknown), Marco Ceresoli, Enrico Davoli, Luca Ansaloni, Maurizio D’Incalci, Massimo Zucchetti	18
16	Pharmacodynamic effects in the cerebrospinal fluid of rats after intravenous administration of different asparaginase formulations 2017 ·Cancer Chemotherapy and Pharmacology ·Andrea Ballerini, Federico Moro, Ilaria Fuso Nerini, (unknown), Angelo Di Clemente, (unknown), Maurizio D’Incalci, Andrea Biondi, Antonella Colombini, Valentino Conter, Luca Porcu, Luigi Cervo, Carmelo Rizzari, Massimo Zucchetti	3
17	Bioreducible Hydrophobin-Stabilized Supraparticles for Selective Intracellular Release 2017 ·ACS Nano ·Daniele Maiolo, Claudia Pigliacelli, Paola Sánchez‐Moreno, Martina Bruna Violatto, Laura Talamini, Ilaria Tirotta, Rosanna Piccirillo, Massimo Zucchetti, Lavinia Morosi, Roberta Frapolli, Gabriele Candiani, Paolo Bigini, Pierangelo Metrangolo, Francesca Baldelli Bombelli	44
18	Bevacizumab-Induced Inhibition of Angiogenesis Promotes a More Homogeneous Intratumoral Distribution of Paclitaxel, Improving the Antitumor Response 2015 ·Molecular Cancer Therapeutics ·Marta Cesca, Lavinia Morosi, Alexander Berndt, Ilaria Fuso Nerini, Roberta Frapolli, Petra Richter, Alessandra Decio, Olaf Dirsch, Edoardo Micotti, Silvia Giordano, Maurizio D’Incalci, Enrico Davoli, Massimo Zucchetti, Raffaella Giavazzi	60
19	The Tyrosine Kinase Inhibitor E-3810 Combined with Paclitaxel Inhibits the Growth of Advanced-Stage Triple-Negative Breast Cancer Xenografts 2012 ·Molecular Cancer Therapeutics ·Ezia Bello, Giulia Taraboletti, Gennaro Colella, Massimo Zucchetti, (unknown), Simonetta Andrea Licandro, Alexander Berndt, Petra Richter, Maurizio D’Incalci, Ennio Cavalletti, Raffaella Giavazzi, Gabriella Camboni, Giovanna Damia	39
20	Metabolic Approach to the Enhancement of Antitumor Effect of Chemotherapy: a Key Role of Acetyl- l -Carnitine 2010 ·Clinical Cancer Research ·Claudio Pisano, Loredana Vesci, Ferdinando Maria Milazzo, Mario B. Guglielmi, (unknown), Marcella Barbarino, Maurizio D’Incalci, Massimo Zucchetti, Giovanna Petrangolini, Monica Tortoreto, Paola Perego, Valentina Zuco, Augusto Orlandi, Daniela Passeri, Paolo Carminati, (unknown), Franco Zunino	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact